Type 2 diabetes treatment in older adults presents a clinical challenge due to a benefit-risk balance that is increasingly compromised by ageing and comorbidities. This review explores the concepts of overtreatment and deprescribing of glucose-lowering treatments, which are essential for optimizing the management of this heterogeneous population. Beyond highlighting their relevance, it underlines current knowledge gaps and the need for further research to develop a more individualized, effective, and safe therapeutic approach for older adults living with type 2 diabetes.
Keywords
Type 2 diabetes, elderly people, personalization, overtreatment, deprescription